TRA-COAT

The TRA-COAT project combats implant infections with a novel coating, featuring antibiofilm activity and triggered antimicrobial release. It focuses on orthopaedic and vascular implants, enhancing durability and reducing resistance development.

The TRA-COAT coating offers multiple advantages:
1. Antibiofilm Activity: Prevents biofilm formation, reducing infection risk.
2. Triggered Antimicrobial Release: Activates only when bacterial growth is detected.
3. Resistance-Proof: Biofilm inhibitors are robust against resistance.
4. Versatile Application: Initially for orthopedic and vascular implants, extendable to other devices.
5. Better Patient Outcomes: Decreases infection rates and antimicrobial resistance.

Technology:
  • Infection prevention
  • Antimicrobial compound/strategy
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Academia
  • Company
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • BSI
  • SSI
  • UTI
  • STI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


University


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed